These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20712783)

  • 1. Better survival and less cardiac morbidity in female patients with thalassemia major: a review of the literature.
    Marsella M; Pepe A; Borgna-Pignatti C
    Ann N Y Acad Sci; 2010 Aug; 1202():129-33. PubMed ID: 20712783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
    Porter JB
    Hemoglobin; 2009; 33 Suppl 1():S37-45. PubMed ID: 20001631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
    Mokhtar GM; Gadallah M; El Sherif NH; Ali HT
    Pediatr Hematol Oncol; 2013 Mar; 30(2):93-103. PubMed ID: 23301991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major.
    Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S
    Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies.
    Taher A; Hershko C; Cappellini MD
    Br J Haematol; 2009 Dec; 147(5):634-40. PubMed ID: 19681884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-thalassemia and pulmonary function.
    Piatti G; Allegra L; Ambrosetti U; Cappellini MD; Turati F; Fiorelli G
    Haematologica; 1999 Sep; 84(9):804-8. PubMed ID: 10477453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular MRI in thalassemia major.
    Wood JC; Noetzli L
    Ann N Y Acad Sci; 2010 Aug; 1202():173-9. PubMed ID: 20712790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and complications in thalassemia.
    Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
    Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron overload in β-thalassemia intermedia: an emerging concern.
    Musallam KM; Cappellini MD; Taher AT
    Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A; Farmakis D; Hatziliami A; Fragodimitri C; Karabatsos F; Joussef J; Mitilineou E; Diamanti-Kandaraki E; Meletis J; Karagiorga M
    Eur J Haematol; 2004 Nov; 73(5):359-66. PubMed ID: 15458515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and treatment of cardiac iron overload in thalassemia.
    Aessopos A; Farmakis D; Andreopoulos A; Tsironi M
    Hemoglobin; 2009; 33 Suppl 1():S87-92. PubMed ID: 20001638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study.
    Marsella M; Borgna-Pignatti C; Meloni A; Caldarelli V; Dell'Amico MC; Spasiano A; Pitrolo L; Cracolici E; Valeri G; Positano V; Lombardi M; Pepe A
    Haematologica; 2011 Apr; 96(4):515-20. PubMed ID: 21228034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congestive heart failure and treatment in thalassemia major.
    Aessopos A; Kati M; Tsironi M
    Hemoglobin; 2008; 32(1-2):63-73. PubMed ID: 18274984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of cardiac iron overload.
    Chu WC; Au WY; Lam WW
    J Magn Reson Imaging; 2012 Nov; 36(5):1052-9. PubMed ID: 23090916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron overload and toxicity: the hidden risk of multiple blood transfusions.
    Shander A; Cappellini MD; Goodnough LT
    Vox Sang; 2009 Oct; 97(3):185-97. PubMed ID: 19663936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
    Mangiagli A; Italia S; Campisi S
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():985-6. PubMed ID: 10091179
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival and complications of beta-thalassemia in Lebanon: a decade's experience of centralized care.
    Charafeddine K; Isma'eel H; Charafeddine M; Inati A; Koussa S; Naja M; Taher A
    Acta Haematol; 2008; 120(2):112-6. PubMed ID: 19001806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.